About the course
Genetic research has been instrumental in developing leading methods used to understand the nature, scope and potential treatment of cancer. Detailed analysis of genetic alterations continues to illuminate the common and specific genetic signatures of various cancers, thereby advancing the field and providing more successful and more targeted treatment options.
This course will expose you to the cutting-edge research that offers attractive development for new anti-cancer drugs and therapeutic strategies. From the differences between sporadic and familial cancers to systemic and targeted level treatment studies, you will learn the history of cancer and how it shaped society and research today.
This course is an elective course in the Stanford Genetics and Genomics Certificate.
You Will Learn
- Current methods involved in cancer research
- Differences between multiple classes of genetic mutations
- How alterations in various cell signaling pathways can lead to different cancers
- Genetic changes involved and required in tumorgenesis
- Targeted therapies for the latest cancer treatments
Time to Complete
You should expect to spend 10-18 hours to complete each course, depending on your familiarity with the topic.
For individual courses, we recommend that you designate 2-3 hours per week to watch video lectures and complete assignments in order to finish within 60 days.
Since the All-Access Plan allows you to access all courses for one year, you can determine how quickly to progress, but you must complete courses with 365 days in order to receive credit.
You can earn the Stanford Genetics and Genomics Certificate by successfully completing the two required and any four elective courses. You may enroll in courses individually or through the All-Access Plan.
Ruth Tennen picked up her first pipette as a summer high-school student in a lab at the University of Connecticut Health Center. She received her bachelor’s degree in molecular biology from Princeton University and her Ph.D. in cancer biology from Stanford University. Her graduate work examined t...
Monte Winslow is an Associate Professor of Genetics and Pathology at Stanford University. Academic Appointments Associate Professor, Genetics Associate Professor, Pathology Member, Bio-X Member, Stanford Cancer Institute Member, Wu Tsai Neurosciences Institute Honors & Awards Stanford Univ...
Academic Appointments Professor, Radiation Oncology - Radiation and Cancer Biology Professor, Genetics Member, Bio-X Member, Maternal & Child Health Research Institute (MCHRI) Member, Stanford Cancer Institute
Dr. Emily Crane grew up in Palo Alto, California. She left the sunshine state to earn her B.A. in Biology from Carleton College in Northfield, Minnesota. She returned to California in 2005, where she enrolled in graduate school at UC Berkeley and began training as a geneticist with Dr. Barbara ...
Academic Appointments Professor, Pathology Professor, Genetics Professor (By courtesy), Biology Member, Bio-X Member, Maternal & Child Health Research Institute (MCHRI) Member, Stanford Cancer Institute Administrative Appointments Director, Genetics Program, SUNY Stony Brook/ Cold Spring H...
Academic Appointments Professor, Pediatrics - Hematology & Oncology Professor, Genetics Member, Bio-X Member, Maternal & Child Health Research Institute (MCHRI) Member, Stanford Cancer Institute Faculty Fellow, Stanford ChEM-H Administrative Appointments Member, Institute for Stem Cell...
Stacey received her B.A. in Biology from Wellesley College and her Ph.D. in Cancer Biology from Stanford University. Her dissertation focused on uncovering new mechanisms for cell cycle control in mouse embryonic stem cells and neural progenitors. She went on to complete a post-doctoral fellowshi...
Videos and materials
Because of COVID-19, many providers are cancelling or postponing in-person programs or providing online participation options.
We are happy to help you find a suitable online alternative.